readthroughSign in
CompanyCTNMNasdaqSan Diego, CA

Contineum Therapeutics

Contineum Therapeutics develops oral small molecule therapies for inflammatory and fibrotic diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 3Latest story